Literature DB >> 9285300

Multivariate evaluation of prognostic determinants for renal cell carcinomas which are metastatic at initial diagnosis.

M Takashi1, T Kawai, T Murase, K Wakai, Y Ohno.   

Abstract

To clarify the relative importance of clinicopathological factors potentially affecting the survival of individuals initially diagnosed as having metastatic renal cell carcinoma (RCC), univariate and multivariate analyses using Cox's proportional hazards model were performed for 111 RCC patients who were admitted to four hospitals in Nagoya, Japan, between 1978 and 1993. Survival time was calculated from the date of diagnosis to the date of death or the end of May, 1995. Nineteen factors (17 clinically applicable before treatment and 2 histological in nature) were included for assessment. Univariate analysis revealed that 10 of the total 19 factors were significantly associated with patient survival. Multivariate analysis found 7 factors to be statistically significant determinants. Survival was further evaluated by categorizing the patients into three groups according to the number of the 7 factors. These groups showed clearly different survivals (log-rank test, p < 0.0001), confirming the importance of the 7 factors as definite determinants. They should therefore prove to be of advantage for classifying metastatic RCC patients when designing clinical prospective studies of immunotherapy and chemotherapy.

Entities:  

Mesh:

Year:  1997        PMID: 9285300     DOI: 10.1007/BF02550925

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  19 in total

Review 1.  Interferon treatment of renal cell carcinoma. Current status and future prospects.

Authors:  S E Krown
Journal:  Cancer       Date:  1987-02-01       Impact factor: 6.860

2.  Serum biomarkers in metastatic renal cell carcinoma.

Authors:  F H Dexeus; C J Logothetis; A Sella; K Fitz; A Striegel; R J Amato; F J Liu
Journal:  Urology       Date:  1991-07       Impact factor: 2.649

3.  Stratification of risk factors in renal cell carcinoma.

Authors:  C Selli; W M Hinshaw; B H Woodard; D F Paulson
Journal:  Cancer       Date:  1983-09-01       Impact factor: 6.860

4.  Value of serum alkaline phosphatase and radionuclide bone scans in patients with renal cell carcinoma.

Authors:  I Atlas; D Kwan; N Stone
Journal:  Urology       Date:  1991-09       Impact factor: 2.649

5.  Renal cell carcinoma: prognostic factors.

Authors:  J U Roosen; U Engel; R H Jensen; E Kvist; G Schou
Journal:  Br J Urol       Date:  1994-08

6.  Multivariate evaluation of prognostic determinants for renal cell carcinoma.

Authors:  M Takashi; Y Nakano; T Sakata; K Miyake; N Hamajima
Journal:  Urol Int       Date:  1993       Impact factor: 2.089

7.  Multiple prognostic factors and outcome analysis in patients with cancer. Communication from the American Joint Committee on Cancer.

Authors:  L P Fielding; D E Henson
Journal:  Cancer       Date:  1993-04-01       Impact factor: 6.860

8.  Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial.

Authors:  R I Fisher; C A Coltman; J H Doroshow; A A Rayner; M J Hawkins; J W Mier; P Wiernik; J D McMannis; G R Weiss; K A Margolin
Journal:  Ann Intern Med       Date:  1988-04       Impact factor: 25.391

9.  The natural history of metastatic renal cell carcinoma: a computer analysis.

Authors:  J B Dekernion; K P Ramming; R B Smith
Journal:  J Urol       Date:  1978-08       Impact factor: 7.450

10.  Prognostic factors and value of adjunctive nephrectomy in patients with stage IV renal cell carcinoma.

Authors:  S Naito; K Kimiya; N Sakamoto; T Soejima; T Ueda; J Kumazawa; Y Osada; T Kurozumi; K Sagiyama; A Ariyoshi
Journal:  Urology       Date:  1991-02       Impact factor: 2.649

View more
  1 in total

Review 1.  Prognostic factors of immunotherapy in metastatic renal cell carcinoma.

Authors:  Peeter Padrik
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.